RA

Rupawali Agrawal

Active Director Director DIN 07105060
DIN 07105060 First appointment Mar 2015 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Mar 2015
Shareholding value •••• Premium profile

About Rupawali Agrawal

Data last updated:

Rupawali Agrawal is a Director at Rabhiaans Biotech Private Limited (since 2019), Director at Manomay Life Care Private Limited (since 2020) and Director at Frenklomed Pharmaceuticals Private Limited (since 2021). The companies operate in Food And Beverages, Home Appliances and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹2.14 Cr; the largest is Rabhiaans Biotech Private Limited at ₹1.65 Cr (FY 2024). Earlier, Rupawali Agrawal was a Director at Ravian Formulation Private Limited (2015–2019).

DIN 07105060
Primary Designation Director
Industry Food And Beverages
First Appointment 25 Mar 2015
Oldest Company Age 12 yrs
Largest company Rabhiaans Biotech Private Limited · ₹1.65 Cr (FY 2024)
Combined revenue ₹2.14 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rabhiaans Biotech Private Limited U24303UR2019PTC010060
Director05 Aug 20192019₹1.65 Cr (FY 2024)Active
Manomay Life Care Private Limited U51397JH2014PTC002110
Director19 Aug 20202014₹48.7 Lakh (FY 2025)Active
Director25 Mar 20212019Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ravian Formulation Private Limited U33111JH2015PTC002764
Director25 Mar 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Rupawali Agrawal

NameDINCompanyDesignation
Surendra Kumar06830651Rabhiaans Biotech Private Limited , Manomay Life Care Private Limited and 1 moreDirector

Directorship timeline

Open interactive timeline →
Frenklomed Pharmaceuticals Private Limited
Rabhiaans Biotech Private Limited
Manomay Life Care Private Limited
Ravian Formulation Private Limited
Premium access

Shareholding and investment profile for Rupawali Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupawali Agrawal

Rupawali Agrawal currently holds 3 directorships: Rabhiaans Biotech Private Limited (Director, since 05 Aug 2019, revenue ₹1.65 Cr (FY 2024)); Manomay Life Care Private Limited (Director, since 19 Aug 2020, revenue ₹48.7 Lakh (FY 2025)); Frenklomed Pharmaceuticals Private Limited (Director, since 25 Mar 2021).

Rupawali Agrawal was first appointed on 25 Mar 2015 as Director at Ravian Formulation Private Limited. The most recent appointment on record is 25 Mar 2021 at Frenklomed Pharmaceuticals Private Limited.

The 2 current companies of Rupawali Agrawal that report revenue have a combined latest revenue of ₹2.14 Cr: Rabhiaans Biotech Private Limited ₹1.65 Cr (FY 2024); Manomay Life Care Private Limited ₹48.7 Lakh (FY 2025).

Rupawali Agrawal held 1 earlier board appointment: Ravian Formulation Private Limited (Director, 25 Mar 2015 to 23 Feb 2019).

The current boards of Rupawali Agrawal's companies include Surendra Kumar (Rabhiaans Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available